FOXP3 and psoriasis: It was recently reported that Cal-BDP combination therapy increases CD4+CD25+Foxp3+CD127lo Tregs and reduces Th17 cells in the blood and skin lesions of patients with psoriasis, suggesting that Cal-BDP combination therapy restores the Treg-T17 balance5.